M. Katherine Tolbert

High Impact

Associate Professor

UAMS

Last publication 2025 Last refreshed 2026-04-18

faculty

22 h-index 112 pubs 1,503 cited

Research Areas

Links

ORCID

OverviewAI-generated summary

M. Katherine Tolbert's research program focuses on the gastrointestinal health of companion animals, particularly dogs and cats. Her work investigates the treatment and management of acute and chronic gastrointestinal diseases. A significant portion of her recent publications stem from her involvement in the Dog Aging Project, examining factors such as diet, physical activity, and cognitive function in aging companion dogs.

Tolbert has authored over 100 peer-reviewed manuscripts and received the Zoetis award for Excellence in Veterinary Research in 2018. Her scholarly metrics include an h-index of 22 and 1,462 total citations. She has collaborated with researchers such as Simon R. Knowles from the University of Arkansas at Monticello on shared publications. Tolbert's clinical interests encompass small animal internal medicine and nutrition, and she holds adjunct professor appointments at the University of Tennessee and is an associate professor at Texas A&M University.

Metrics

h-index: 22
Publications: 112
Citations: 1,503

Selected Publications

Orally administered cholestyramine increases fecal bile acid excretion in healthy dogs (2025)

1 citation DOI OpenAlex
Fecal and Clinical Profiles of Dogs With Chronic Enteropathies Treated With Bile Acid Sequestrants for 5–47 Months: A Retrospective Case Series (2025)

2 citations DOI OpenAlex
Comparing owner reported and genetic breed identification reveals high concordance in a large cohort from the Dog Aging Project (2025)

1 citation DOI OpenAlex
Microbial Gene Profiling and Targeted Metabolomics in Fecal Samples of Dogs With Chronic Enteropathy With or Without Increased Dysbiosis Index (2025)

3 citations DOI OpenAlex
Treatment of Hypovitaminosis D With Cholecalciferol in Dogs With Protein-Losing Enteropathies: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial (2025)

2 citations DOI OpenAlex
Adverse events after fecal microbiota transplantation in nine cats: a case series (2025)

1 citation DOI OpenAlex
Pre-clinical enteropathy in healthy soft-coated wheaten terriers (2025)

5 citations DOI OpenAlex
Test of Rapamycin in Aging Dogs (TRIAD): study design and rationale for a prospective, parallel-group, double-masked, randomized, placebo-controlled, multicenter trial of rapamycin in healthy middle-aged dogs from the Dog Aging Project (2025)

10 citations DOI OpenAlex
Prolonged storage reduces viability of Peptacetobacter (Clostridium) hiranonis and core intestinal bacteria in fecal microbiota transplantation preparations for dogs (2025)

3 citations DOI OpenAlex
Harnessing the microbiome: probiotics, antibiotics and their role in canine and feline gastrointestinal disease (2024)

3 citations DOI OpenAlex
Pharmacodynamics of 2 dosages of orally administered esomeprazole in client-owned, healthy dogs: A prospective, crossover study (2024)

3 citations DOI OpenAlex
Dysbiosis index and fecal concentrations of sterols, long-chain fatty acids and unconjugated bile acids in dogs with inflammatory protein-losing enteropathy (2024)

5 citations DOI OpenAlex
Clinical Guidelines for Fecal Microbiota Transplantation in Companion Animals (2024)

29 citations DOI OpenAlex
Dog and owner demographics impact dietary choices in Dog Aging Project cohort (2024)

12 citations DOI OpenAlex
The companion dog as a model for inflammaging: a cross-sectional pilot study (2024)

20 citations DOI OpenAlex